Latest News & Features
Big Pharma
The EU General Court has backed the European Commission’s decision to fine pharma company Lundbeck and a number of generic producers. 12 September 2016
Americas
The US Court of Appeals for the Federal Circuit affirmed a ruling from a district court yesterday in a case between UCB and Yeda Research and Development, finding that UCB did not infringe the patent in dispute. 9 September 2016
Americas
The US Federal Trade Commission announced yesterday that it has approved a final order in Mylan’s $7.2 billion acquisition of Meda, a Swedish drug maker, deciding that the activity would be anticompetitive. 9 September 2016
Americas
Aralez Pharmaceuticals has acquired the US and Canadian rights to Zontivity in an agreement with Merck. 8 September 2016
Asia
Japan’s government officials have warned the UK that the Asian country may reconsider its research and development activities in the UK following Brexit. 8 September 2016
Asia
An increasing number of biologics and biosimilar products are appearing in the Thai market, but there are challenges concerning IP protection and regulation, say Alan Adcock and Atthachai Homhuan of Tilleke & Gibbins. 8 September 2016
Americas
The US District Court for the Southern District of Florida ruled yesterday that Apotex did not infringe Amgen patents centring on its biologic drug Neulasta. 7 September 2016
Americas
Eli Lilly has filed a complaint against Aurobindo Pharma for allegedly infringing a patent covering the drug Cialis. 7 September 2016
Asia-Pacific
More than 2,000 medicine brands treating common conditions will drop in price for millions of Australians from October 1, according to the Australian government’s Department of Health. 6 September 2016
Big Pharma
Pharmaceutical company Alvogen has launched the first generic version of Copaxone in Europe under the name Remurel. 6 September 2016